Publication: Knockdown of circRNA circEBF1 inhibits cutaneous squamous cell carcinoma progression by regulating the miR-1247-5p/CSF3 axis
Authors
Yin, Dong ; Wei, Guo ; Sun, Xiaoyan ; Yin, Yan
item.page.secondaryauthor
item.page.director
Publisher
Universidad de Murcia, Departamento de Biologia Celular e Histiologia
publication.page.editor
publication.page.department
DOI
https://doi.org/10.14670/HH-18-468
item.page.type
info:eu-repo/semantics/article
Description
Abstract
Background. Cutaneous squamous cell
carcinoma (CSCC) is one of the causes of cancer-related
death worldwide. Circular RNAs (circRNAs) play a vital
role in the pathological process of many malignant
tumors. This study aimed to explore the specific role and
potential mechanism of circRNA EBF transcription
factor 1 (circEBF1) in CSCC.
Methods. The levels of circEBF1, microRNA-1247-
5p (miR-1247-5p) and colony stimulating factor 3
(CSF3) were determined by quantitative real-time PCR
and Western blot. Cell proliferation was assessed by
colony formation assay. Cell migration, invasion and
apoptosis were evaluated by Transwell, wound healing,
flow cytometry and Western blot assays. Cellular
glycolysis, including glucose consumption, lactate
production, and ATP level, was detected by commercial
kits. The binding relationship between miR-1247-5p and
circEBF1 or CSF3 was verified by dual-luciferase
reporter assay, RNA immunoprecipitation (RIP) assay
and RNA pull-down assay. Xenograft experiment was
conducted to analyze tumor growth in vivo.
Results. circEBF1 and CSF3 were up-regulated,
while miR-1247-5p was down-regulated in CSCC
tissues and cells. Interference of circEBF1 hindered the
proliferation, migration, invasion, and glycolysis of
CSCC cells and promoted apoptosis. In addition,
circEBF1 sponged miR-1247-5p to regulate CSCC cell
development. Also, miR-1247-5p suppressed CSCC cell
progression by inhibiting CSF3. Moreover, depletion of
circEBF1 blocked CSCC tumor growth in vivo.
Conclusion. Down-regulation of circEBF1 impeded
CSCC progression by regulating the miR-1247-5p/CSF3
pathway, suggesting that circEBF1 might be a promising
therapeutic target for CSCC
publication.page.subject
Citation
Histology and Histopathology Vol. 37, nº10 (2022)
item.page.embargo
Ir a EstadÃsticas
Este Ãtem está sujeto a una licencia Creative Commons. http://creativecommons.org/licenses/by-nc-nd/4.0/